FRANKFURT: German medical company Fresenius SE said Tuesday its net profit fell 2 percent on one-time effects despite improved sales during the second quarter.
The Bad Homburg-based company earned euro110 million ($157.3 million) in the April-June period compared with euro112 million a year earlier.
The dip was blamed on costs related to its acquisition of APP Pharmaceuticals and accounting for an exchangeable bond.
Sales rose 21 percent to euro3.5 billion compared with euro2.9 billion a year earlier.
Fresenius provides products and services for hospital and out-patient care and specializes in dialysis treatments. - AP
Latest business news from AP-Wire
Did you find this article insightful?